272 related articles for article (PubMed ID: 20360147)
1. Meta-analysis of association between matrix metalloproteinases 2, 7 and 9 promoter polymorphisms and cancer risk.
Peng B; Cao L; Ma X; Wang W; Wang D; Yu L
Mutagenesis; 2010 Jul; 25(4):371-9. PubMed ID: 20360147
[TBL] [Abstract][Full Text] [Related]
2. Current evidence on the relationship between five polymorphisms in the matrix metalloproteinases (MMP) gene and lung cancer risk: a meta-analysis.
Hu C; Wang J; Xu Y; Li X; Chen H; Bunjhoo H; Xiong W; Xu Y; Zhao J
Gene; 2013 Mar; 517(1):65-71. PubMed ID: 23313298
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in the promoter regions of matrix metalloproteinases 1 and 3 and cancer risk: a meta-analysis of 50 case-control studies.
Peng B; Cao L; Wang W; Xian L; Jiang D; Zhao J; Zhang Z; Wang X; Yu L
Mutagenesis; 2010 Jan; 25(1):41-8. PubMed ID: 19843588
[TBL] [Abstract][Full Text] [Related]
4. Functional polymorphisms and haplotypes in the promoter of the MMP2 gene are associated with risk of nasopharyngeal carcinoma.
Zhou G; Zhai Y; Cui Y; Qiu W; Yang H; Zhang X; Dong X; He Y; Yao K; Zhang H; Peng Y; Yuan X; Zhi L; Zhang X; He F
Hum Mutat; 2007 Nov; 28(11):1091-7. PubMed ID: 17607721
[TBL] [Abstract][Full Text] [Related]
5. The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer.
O-Charoenrat P; Khantapura P
Oral Oncol; 2006 Mar; 42(3):257-67. PubMed ID: 16275157
[TBL] [Abstract][Full Text] [Related]
6. Functional haplotypes in the promoter of matrix metalloproteinase-2 and lung cancer susceptibility.
Zhou Y; Yu C; Miao X; Wang Y; Tan W; Sun T; Zhang X; Xiong P; Lin D
Carcinogenesis; 2005 Jun; 26(6):1117-21. PubMed ID: 15731163
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases 1, 2, 3 and 9 functional single-nucleotide polymorphisms in idiopathic recurrent spontaneous abortion.
Pereza N; Ostojić S; Volk M; Kapović M; Peterlin B
Reprod Biomed Online; 2012 May; 24(5):567-75. PubMed ID: 22406112
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of genes involved in extracellular matrix remodeling and abdominal aortic aneurysm.
Saracini C; Bolli P; Sticchi E; Pratesi G; Pulli R; Sofi F; Pratesi C; Gensini GF; Abbate R; Giusti B
J Vasc Surg; 2012 Jan; 55(1):171-179.e2. PubMed ID: 22094117
[TBL] [Abstract][Full Text] [Related]
9. Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes.
Zhou Y; Yu C; Miao X; Tan W; Liang G; Xiong P; Sun T; Lin D
Carcinogenesis; 2004 Mar; 25(3):399-404. PubMed ID: 14604886
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms of matrix metalloproteinases: susceptibility and prognostic implications for prostate cancer.
Dos Reis ST; Pontes J; Villanova FE; Borra PM; Antunes AA; Dall'oglio MF; Srougi M; Leite KR
J Urol; 2009 May; 181(5):2320-5. PubMed ID: 19303106
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase (MMP) -2, -7 and -9 promoter polymorphisms in colorectal cancer in ethnic Kashmiri population - A case-control study and a mini review.
Banday MZ; Sameer AS; Mir AH; Mokhdomi TA; Chowdri NA; Haq E
Gene; 2016 Sep; 589(1):81-89. PubMed ID: 27222481
[TBL] [Abstract][Full Text] [Related]
12. [Association of functional polymorphisms in matrix metalloproteinase-2 (MMP-2) and MMP-9 genes with risk of gastric cancer in a Chinese population].
Zhang XM; Miao XP; Xiong P; Yu CY; Tan W; Qu SN; Sun T; Zhou YF; Lin DX
Ai Zheng; 2004 Nov; 23(11):1233-7. PubMed ID: 15522165
[TBL] [Abstract][Full Text] [Related]
13. Correlation between a single nucleotide polymorphism in the matrix metalloproteinase-2 promoter and risk of lung cancer.
Yu C; Pan K; Xing D; Liang G; Tan W; Zhang L; Lin D
Cancer Res; 2002 Nov; 62(22):6430-3. PubMed ID: 12438229
[TBL] [Abstract][Full Text] [Related]
14. A functional polymorphism in the matrix metalloproteinase-2 gene promoter (-1306C/T) is associated with risk of development but not metastasis of gastric cardia adenocarcinoma.
Miao X; Yu C; Tan W; Xiong P; Liang G; Lu W; Lin D
Cancer Res; 2003 Jul; 63(14):3987-90. PubMed ID: 12873995
[TBL] [Abstract][Full Text] [Related]
15. Association of matrix metalloproteinases (MMP2, MMP7 and MMP9) genetic variants with left ventricular dysfunction in coronary artery disease patients.
Mishra A; Srivastava A; Mittal T; Garg N; Mittal B
Clin Chim Acta; 2012 Oct; 413(19-20):1668-74. PubMed ID: 22664146
[TBL] [Abstract][Full Text] [Related]
16. Clinical implications of matrix metalloproteinase-1, -3, -7, -9, -12, and plasminogen activator inhibitor-1 gene polymorphisms in colorectal cancer.
Woo M; Park K; Nam J; Kim JC
J Gastroenterol Hepatol; 2007 Jul; 22(7):1064-70. PubMed ID: 17608852
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of associations between four polymorphisms in the matrix metalloproteinases gene and gastric cancer risk.
Yang TF; Guo L; Wang Q
Asian Pac J Cancer Prev; 2014; 15(3):1263-7. PubMed ID: 24606450
[TBL] [Abstract][Full Text] [Related]
18. Fetal MMP2/MMP9 polymorphisms and intrauterine growth restriction risk.
Gremlich S; Nguyen D; Reymondin D; Hohlfeld P; Vial Y; Witkin SS; Gerber S
J Reprod Immunol; 2007 Jun; 74(1-2):143-51. PubMed ID: 17367869
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in the promoter regions of the matrix metalloproteinases-7, -9 and the risk of endometriosis and adenomyosis in China.
Shan K; Lian-Fu Z; Hui D; Wei G; Na W; Xia J; Yan L
Mol Hum Reprod; 2006 Jan; 12(1):35-9. PubMed ID: 16455621
[TBL] [Abstract][Full Text] [Related]
20. FAS promoter polymorphisms and cancer risk: a meta-analysis based on 34 case-control studies.
Zhang Z; Xue H; Gong W; Wang M; Yuan L; Han S; Zhang Z
Carcinogenesis; 2009 Mar; 30(3):487-93. PubMed ID: 19168581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
